Guobang Pharmaceutical (605507.SH) released results for the first three quarters, with net profit of 471 million yuan to mother, a year-on-year decrease of 29.67%

Zhitongcaijing · 2d ago

According to the Zhitong Finance App, Guobang Pharmaceutical (605507.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 4.589 billion yuan, an increase of 2.66%; net profit to mother of 471 million yuan, a year-on-year decrease of 29.67%; deducted non-net profit of 447 million yuan, a year-on-year decrease of 27.88%; and basic earnings per share.